glp 1 not working for weight loss GLP-1 Agonists Obesity In Non-Diabetic Patients: Game Changer Or Overhyped? A Critical Analysis GlobalRPH Rx Trends: Real-World Data on
Description
Only a small fraction of people who qualify for GLP-1 medications receive them
Since obesity is a major risk factor for both OA and diabetes, this has led to the exploration of GLP-1RA as a potential treatment for OA due to its weight loss and anti-inflammatory properties
These Bellwether trials give the manufacturers, but also the plaintiffs, attorneys, the steering committee, an idea of what are the types of damages that are likely to award in these cases
Here the evidence is earlier, but its growing quickly
